Early markers of cardiovascular disease

Gaston K Kapuku1, Gregory A Harshfield, Harry C Davis

  • 1Georgia Prevention Institute, Department of Pediatrics, Medical College of Georgia, Augusta, GA 30912-4534, USA. gkapuku@mail.mcg.edu

Vascular Pharmacology
|October 3, 2006
PubMed

Insights

Assessing endothelial function via ultrasound is crucial for early cardiovascular disease detection. Improving the reliability of these noninvasive tests, especially in children, is essential for effective prevention and treatment strategies.

Area of Science:

  • Cardiovascular Research
  • Vascular Biology
  • Diagnostic Imaging

Background:

  • Endothelial function is a key pre-clinical marker for cardiovascular disease.
  • Nitric oxide from the endothelium causes vasodilation, lowering blood pressure and preventing cardiac structural changes.
  • Ultrasound offers noninvasive assessment of endothelial function, detecting alterations before anatomical changes occur.

Purpose of the Study:

  • To provide an overview of challenges in clinically determining endothelium-dependent arterial dilatation using ultrasound.
  • To highlight the need for improved reliability and reproducibility of ultrasound-derived endothelial function measures.
  • To emphasize the importance of pediatric population studies for cardiovascular disease prevention.

Main Methods:

  • Review of current ultrasound techniques for assessing endothelial function.
  • Discussion of challenges in achieving reliable and reproducible measurements.
  • Analysis of the role of endothelial function in cardiovascular health.

Main Results:

  • Ultrasound can noninvasively assess endothelial function, identifying early signs of cardiovascular issues.
  • Current ultrasound methods for measuring endothelial function face challenges in reliability and reproducibility.
  • Pediatric studies are crucial for understanding and preventing cardiovascular disease progression.

Conclusions:

  • Enhancing the accuracy and consistency of ultrasound-based endothelial function assessment is critical.
  • Focusing on pediatric populations is vital for long-term cardiovascular disease prevention and treatment.
  • Early detection and intervention based on endothelial function can mitigate cardiovascular risks.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...